Changchun BCHT Biotechnology Co Ordinary Shares - Class A 688276
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥26.27
- Day Range
- ¥27.31–30.74
- 52-Week Range
- ¥21.18–68.50
- Bid/Ask
- ¥30.69 / ¥30.70
- Market Cap
- ¥12.70 Bil
- Volume/Avg
- 9.1 Mil / 3.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 19.72
- Price/Sales
- 5.81
- Dividend Yield (Trailing)
- 0.57%
- Dividend Yield (Forward)
- 0.57%
- Total Yield
- 0.57%
Company Profile
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,241
- Website
- http://www.bchtpharm.com
Comparables
Valuation
|
Metric
|
688276
|
300142
|
300122
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.72 | 65.42 | 11.23 |
Price/Book Value | 2.64 | 2.07 | 2.11 |
Price/Sales | 5.81 | 5.81 | 1.43 |
Price/Cash Flow | 15.15 | 18.10 | 9.26 |
Price/Earnings
688276
300142
300122
Financial Strength
|
Metric
|
688276
|
300142
|
300122
|
|---|---|---|---|
Quick Ratio | 1.96 | 2.51 | 1.37 |
Current Ratio | 2.27 | 2.94 | 2.07 |
Interest Coverage | 451.26 | 24.73 | 76.85 |
Quick Ratio
688276
300142
300122
Profitability
|
Metric
|
688276
|
300142
|
300122
|
|---|---|---|---|
Return on Assets (Normalized) | 12.17% | 1.93% | 11.64% |
Return on Equity (Normalized) | 15.11% | 3.16% | 19.62% |
Return on Invested Capital (Normalized) | 14.74% | 2.01% | 17.67% |
Return on Assets
688276
300142
300122
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Dgnzjymt | Qjr | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Qxswyvvndm | Gcbfqvy | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Gzmkqfg | Svgkc | $48.4 Bil | |||
| Viatris Inc
VTRS
| Jbmnxrpnz | Qlttj | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Lmrghjbm | Gwbk | $13.5 Bil | |||
| Catalent Inc
CTLT
| Mwwljkrk | Wprygj | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Xhkdrxdt | Rbrlfkm | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Rygxpfmv | Pksx | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Nhvljyny | Mkj | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Cmdzqknb | Gqzj | $2.3 Bil |
United States